NEW YORK (GenomeWeb News) - BioMicro Systems said today it has closed a round of Series B financing with investors vSpring, Nanostart, and Staley Capital Advisors.
 
BioMicro, which markets the MAUI hybridization product line, did not disclose the amount of funding it received in this round, but said the new investments bring the total it has raised since inception to $10 million.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.